IonQ, Inc. (IONQ) is a quantum-computing company that builds trapped-ion quantum systems and a full-stack hardware-and-software platform. The $72 central target used here is calculated from roughly ten current, attributable analyst targets, not copied from any single website. The low-to-high range is approximately $49 to $100, and the calculated mean is about $71.90, rounded to $72.
The bullish end is led by Rosenblatt (John McPeake) and B. Riley (Craig Ellis), each at $100, followed by Jefferies at $85, Wedbush at $75, Northland (Nehal Chokshi) and Cantor Fitzgerald (Troy Jensen) at $70, and Needham at $65. The cautious side includes Morgan Stanley (Scott Fessler) at $49 with an Equal-weight view, J.P. Morgan (Peter Peng) at $50, and DA Davidson at $55.
Analysts broadly agree on the long-term opportunity—J.P. Morgan estimates a $46 billion to $97 billion total addressable market by 2035—but they split sharply on how much of that future is already priced in. Bullish firms emphasize technology leadership and commercial momentum; cautious firms argue the valuation already discounts years of rapid growth, and they point to dilution and losses. The mean is not a guarantee; it simply reflects the midpoint of these competing views.
Shares closed at $32.43 on October 28, 2026, well below the 52-week high of $73.65 set in June 2026 and near the lower end of a 52-week range of roughly $25.89 to $73.65. Reaching $72 would require a gain of about 122% from the latest close—an unusually large move for a 12-month horizon.
Fundamentals are improving but remain deeply unprofitable. Revenue reached $80.05 million in Q2 2026, up roughly 287% year over year, yet the company posted an operating loss near $327 million and negative EPS (earnings per share). A recently priced $2 billion equity offering and an all-stock acquisition have added share-count and integration risk. Against that backdrop, the path to $72 would likely require sustained triple-digit revenue growth, visible progress toward commercial-scale quantum systems, and investor willingness to pay a premium valuation through a period of heavy investment.
Several factors could support a higher stock price. Revenue is compounding rapidly, and IonQ has secured validating relationships with entities such as the U.S. Air Force Research Laboratory, Hyundai, AstraZeneca, EPB, and Ansys. A $7.5 million follow-on award for quantum networking and a Cambridge quantum partnership announced in late 2026 signal continued government and academic adoption. Analysts including Rosenblatt, B. Riley, and Jefferies argue IonQ's full-stack approach—spanning compute, networking, security, and sensing—positions it to capture a large share of an expanding quantum market, which Morgan Stanley projects could exceed $100 billion annually by 2040. Any acceleration in commercial bookings, margin improvement, or positive analyst revisions could compress the wide gap between the current price and the target.
The risks are substantial. The stock trades at a market capitalization near $13.9 billion while generating losses, leaving it highly sensitive to any slowdown in revenue growth or disappointment in the technology roadmap. The $2 billion equity raise and stock-based acquisition dilute existing shareholders, and quantum commercialization remains at an early stage, with limited performance and scale relative to classical systems. Cautious analysts explicitly cite valuation as the main obstacle—J.P. Morgan initiated coverage at Neutral on the view that long-term potential is already "priced into" the stock. Sector sentiment has also cooled: shares sit more than 55% below their June 2026 high, and quantum-computing peers have repriced sharply amid broader concerns about speculative technology valuations.
IONQ is trading below its 20-day and 60-day moving averages, reflecting a persistent downtrend since the June 2026 peak. The $30 area has acted as near-term support in recent sessions, while the 52-week low of about $25.89 marks a more durable floor. On the upside, the $36–$40 zone represents the first significant resistance band, followed by the mid-$40s. The former peak near $73.65 is the most important longer-term reference level—it sits just above the $72 target and would need to be recaptured for the stock to re-enter its prior uptrend structure.
Most analyst price targets reflect a research horizon of roughly 12 months, though individual firms may differ. Investors should watch the Q3 2026 earnings report due around November 5, 2026, particularly revenue growth, guidance, cash consumption, and any update on the integration of recent acquisitions. Also important are new commercial or government contracts, further analyst target revisions, progress on quantum error correction and qubit count, and any dilution tied to the equity offering. Broader moves in speculative technology names and interest-rate expectations are likely to influence sentiment as much as company-specific news.
For traders who prefer a data-driven, systematic view alongside fundamental research, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. This can help you discover new opportunities, monitor existing positions, and spot shifts in trend more efficiently than manual chart review. Explore the signals to see how the system is currently reading IONQ's technical setup alongside your own due diligence.
Can IonQ reach $72? The question frames a move of roughly 122% from the latest close of $32.43—a very large advance that would require both continued exceptional revenue growth and a sustained willingness by investors to pay a premium for early-stage quantum leadership. The bullish case rests on rapid bookings growth, high-profile partnerships, and a multi-billion-dollar addressable market; the bearish case rests on valuation, dilution, and deep ongoing losses. With targets ranging from $49 to $100, the analyst community itself is divided. The $72 figure is a calculated midpoint, not a forecast, and it should be read as a reference for how far the stock would need to travel rather than a prediction that it will get there. The Q3 earnings report and the pace of commercialization will be the most important near-term signposts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IONQ has been closely correlated with RGTI. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if IONQ jumps, then RGTI could also see price increases.
| Ticker / NAME | Correlation To IONQ | 1D Price Change % | ||
|---|---|---|---|---|
| IONQ | 100% | -0.99% | ||
| RGTI - IONQ | 88% Closely correlated | -6.39% | ||
| QBTS - IONQ | 86% Closely correlated | -8.63% | ||
| UMAC - IONQ | 58% Loosely correlated | -6.60% | ||
| OSS - IONQ | 50% Loosely correlated | -5.74% | ||
| SSYS - IONQ | 49% Loosely correlated | -1.80% | ||
More | ||||
| Ticker / NAME | Correlation To IONQ | 1D Price Change % |
|---|---|---|
| IONQ | 100% | -0.99% |
| IONQ (4 stocks) | 64% Loosely correlated | -2.67% |
| Computer Processing Hardware (40 stocks) | 46% Loosely correlated | -2.87% |